 440 women will be randomly divided into 2 groups using computer generated random numbers. Group 1 study group will include 220 women who will receive DHEA 25 mg t.d.s DHEA, Natrol , USA twice daily for 12 weeks before starting IVFICSI cycle. Group 2 will include 220 women who will receive an oral placebo similar in colour, size and structure to DHEA.. All women fulfilling the inclusion criteria will be invited to participate in the study. A written informed consent will be taken and only women signing the consent will be included in the study. 